One of the most important signalling pathways in melanoma is the MAPK pathway, a pathway that centralises aerobic cellular metabolism and affects mitochondrial metabolism where there is an accumulation of reducing species such as NADH; it is also an activator of ERK kinase and promotes the expression of MITF via MEK [61]. This evidence concerns the gene MITF and melanoma.